Preparation and clinical evaluation of a novel colchicine mucoadhesive gel for the treatment of aphthous stomatitis
Phase 3
Recruiting
- Conditions
- Aphthous stomatitis.
- Registration Number
- IRCT20191106045356N8
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with aphthous stomatitis starting up to two days
Patient between 18-65 years old
No pregnancy and lactation
No history of allergies to colchicine
Exclusion Criteria
Patients with skin diseases
Sensitivity to colchicine or any of the components of the product
Do not use the drug for two consecutive days
Exacerbation of the aphthous stomatitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of pain. Timepoint: At the beginning of treatment and after every 2 to 10 days, the condition of aphthous lesions is evaluated for pain intensity (score 0 to 4). Method of measurement: Scoring pain using a questionnaire.;Redness and inflammation. Timepoint: At the beginning of treatment and after every 2 to 10 days, the condition of aphthous lesions is evaluated for the severity of redness and inflammation (score 0 to 4). Method of measurement: Scoring severe redness and inflammation using a questionnaire.;Total area of ??aphthous lesions. Timepoint: At the beginning of treatment and after every 2 to 10 days, the condition of the aphthous lesions is evaluated in terms of the total area of ??the aphthous lesions. Method of measurement: Determining the total area of ??aphthous lesions through Fiji software.
- Secondary Outcome Measures
Name Time Method